Cargando…
Harnessing Biological Insight to Accelerate Tuberculosis Drug Discovery
[Image: see text] Tuberculosis (TB) is the leading cause of mortality globally resulting from an infectious disease, killing almost 1.6 million people annually and accounting for approximately 30% of deaths attributed to antimicrobial resistance (AMR). This despite the widespread administration of a...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Chemical
Society
2019
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704484/ https://www.ncbi.nlm.nih.gov/pubmed/31361123 http://dx.doi.org/10.1021/acs.accounts.9b00275 |